| Rank | Company | Total assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|---|
| 101 | $567M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 102 | $565M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 103 | $562M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 104 | $561M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 105 | $558M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 106 | $558M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 107 | $544M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 108 | $536M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 109 | $533M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 110 | $527M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 111 | $522M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 112 | $522M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 113 | $521M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 114 | $519M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 115 | $512M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 116 | $500M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 117 | $491M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 118 | $489M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 119 | $487M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 120 | $480M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 121 | $472M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 122 | $459M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 123 | $442M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 124 | $437M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 125 | $436M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 126 | $435M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 127 | $434M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 128 | $425M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 129 | $423M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 130 | $417M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 131 | $412M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 132 | $412M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 133 | $406M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 134 | $405M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 135 | $397M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 136 | $397M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 137 | $395M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 138 | $394M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 139 | $392M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 140 | $383M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 141 | $381M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 142 | $379M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 143 | $377M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 144 | $371M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 145 | $370M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 146 | $369M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 147 | $368M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 148 | $362M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 149 | $350M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 150 | $345M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 151 | $338M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 152 | $331M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 153 | $331M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 154 | $327M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 155 | $324M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 156 | $319M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 157 | $317M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 158 | $317M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 159 | $311M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 160 | $303M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 161 | $303M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 162 | $302M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 163 | $299M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 164 | $297M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 165 | $288M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 166 | $288M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 167 | $287M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 168 | $285M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 169 | $283M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 170 | $281M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 171 | $281M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 172 | $279M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 173 | $274M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 174 | $265M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 175 | $263M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 176 | $260M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 177 | $254M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 178 | $254M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 179 | $254M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 180 | $253M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 181 | $252M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 182 | $251M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 183 | $250M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 184 | $250M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 185 | $249M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 186 | $248M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 187 | $246M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 188 | $246M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 189 | $244M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 190 | $239M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 191 | $239M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 192 | $232M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 193 | $232M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 194 | $225M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 195 | $224M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 196 | $221M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 197 | $219M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 198 | $215M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 199 | $215M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 200 | $207M | Healthcare | Pharmaceuticals | United States | Nasdaq |